MnDPDP enhanced magnetic resonance imaging of focal liver lesions.

@article{King2002MnDPDPEM,
  title={MnDPDP enhanced magnetic resonance imaging of focal liver lesions.},
  author={Leonard J King and Guy J. C. Burkill and Erica D. Scurr and Panagiotis Vlavianos and I Murray-Lyons and Jeremiah C. Healy},
  journal={Clinical radiology},
  year={2002},
  volume={57 12},
  pages={
          1047-57
        }
}
Mangafodipir trisodium (MnDPDP) is a contrast agent for use in magnetic resonance imaging (MRI) of the liver. The agent is taken up by normal hepatocytes resulting in increased signal on T1-weighted imaging, and is excreted in the biliary system. Hepatocyte-containing liver neoplasms such as hepatomas or focal nodular hyperplasia (FNH), take up MnDPDP and demonstrate varying degrees of enhancement. Metastatic liver deposits and primary liver tumours of non-hepatocyte origin do not typically… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-5 of 5 citations